Literature DB >> 22679157

An unusual presentation of cortical venous thrombosis and its association with typical antipsychotics.

Sreeman Narayan Andole1.   

Abstract

A 41-year-old patient with schizophrenia was admitted to hospital following episodes of unexplained collapse attacks and on and off episodes of frontal headaches for 3 months. After three such episodes of loss of consciousness in 2 weeks duration and subsequent spontaneous recovery, his evaluation which included MRI scan of head revealed extensive cortical venous thrombosis. He was on zuclopenthixol (thioxanthene group) for several months for schizophrenia and was under regular psychiatric evaluation. He was treated for simple lower respiratory infection a week prior to admission. Other causes for any clotting disorders including vasculitic and thrombophilic screen were negative. There was no evidence of focal neurology on examination. Systemic examination was otherwise unremarkable. He was treated initially with unfractionated heparin and subsequently changed to warfarin with target international normalised ratio between two and three for at least 6 months and psychiatrist was advised to stop zuclopenthixol.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22679157      PMCID: PMC3189645          DOI: 10.1136/bcr.07.2011.4542

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  6 in total

1.  Antipsychotic drugs and venous thromboembolism.

Authors:  J F Knudson; C Kortepeter; G M Dubitsky; S R Ahmad; M Chen
Journal:  Lancet       Date:  2000-07-15       Impact factor: 79.321

2.  Cerebral venous thrombosis: anticoagulants or thrombolyic therapy?

Authors:  H T Benamer; I Bone
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-10       Impact factor: 10.154

3.  Cerebral venous thrombosis presenting with cerebellar ataxia and cortical blindness.

Authors:  Samia Ben Sassi; Habiba Mizouni; Fatma Nabli; Lamia Kallel; Mounir Kefi; Fayçal Hentati
Journal:  J Stroke Cerebrovasc Dis       Date:  2010-06-09       Impact factor: 2.136

Review 4.  Cerebral venous thrombosis.

Authors:  A Ameri; M G Bousser
Journal:  Neurol Clin       Date:  1992-02       Impact factor: 3.806

5.  [Cerebral venous thrombosis: when etiology makes the difference].

Authors:  A Alonso-Cánovas; J Masjuan; J González-Valcárcel; M C Matute-Lozano; J García-Caldentey; M A Alonso-Arias; A García-Avello
Journal:  Neurologia       Date:  2009-09       Impact factor: 3.109

6.  Clinical features, course and outcome in deep cerebral venous system thrombosis: an analysis of 32 cases.

Authors:  Thomas Pfefferkorn; Isabelle Crassard; Jennifer Linn; Martin Dichgans; Monique Boukobza; Marie-Germaine Bousser
Journal:  J Neurol       Date:  2009-06-18       Impact factor: 4.849

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.